EPCAM and Familial prostate cancer: For example, the CellSearch® system uses nanoparticles labeled with antibodies that target the epithelial cell adhesion molecule (EpCAM) to separate CTC from other cells present in the blood of patients with metastatic colorectal, breast, or prostate cancer.